Go Pro

CareCloud (CCLD) Competitors

CareCloud logo
$2.04 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.06 +0.02 (+0.98%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CCLD vs. ONMD, AMWL, OPRX, HCAT, and DH

Should you buy CareCloud stock or one of its competitors? CareCloud's main competitors and comparable companies include OneMedNet (ONMD), American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), and Definitive Healthcare (DH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does CareCloud compare to OneMedNet?

CareCloud (NASDAQ:CCLD) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

CareCloud has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.72$10.80M$0.0729.14
OneMedNet$1.36M23.98-$2.80M-$0.16N/A

In the previous week, OneMedNet had 4 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for OneMedNet and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.63 beat OneMedNet's score of 0.34 indicating that CareCloud is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OneMedNet
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has a net margin of 6.21% compared to OneMedNet's net margin of -584.20%. CareCloud's return on equity of 27.07% beat OneMedNet's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
OneMedNet -584.20%N/A -521.20%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

10.2% of CareCloud shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

CareCloud has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

Summary

CareCloud beats OneMedNet on 12 of the 15 factors compared between the two stocks.

How does CareCloud compare to American Well?

CareCloud (NASDAQ:CCLD) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

CareCloud has a net margin of 6.21% compared to American Well's net margin of -35.75%. CareCloud's return on equity of 27.07% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
American Well -35.75%-30.12%-22.30%

10.2% of CareCloud shares are held by institutional investors. Comparatively, 56.1% of American Well shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 12.8% of American Well shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CareCloud has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, American Well has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

American Well has a consensus price target of $9.50, suggesting a potential downside of 25.73%. Given American Well's higher possible upside, analysts clearly believe American Well is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
American Well
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

CareCloud has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.72$10.80M$0.0729.14
American Well$249.32M0.85-$95.70M-$4.77N/A

In the previous week, CareCloud had 3 more articles in the media than American Well. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for American Well. CareCloud's average media sentiment score of 0.63 beat American Well's score of 0.00 indicating that CareCloud is being referred to more favorably in the media.

Company Overall Sentiment
CareCloud Positive
American Well Neutral

Summary

CareCloud beats American Well on 10 of the 15 factors compared between the two stocks.

How does CareCloud compare to OptimizeRx?

CareCloud (NASDAQ:CCLD) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

CareCloud has higher revenue and earnings than OptimizeRx. CareCloud is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.72$10.80M$0.0729.14
OptimizeRx$109.43M1.44$5.13M$0.2336.48

In the previous week, OptimizeRx had 1 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for OptimizeRx and 3 mentions for CareCloud. OptimizeRx's average media sentiment score of 0.72 beat CareCloud's score of 0.63 indicating that OptimizeRx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OptimizeRx
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

10.2% of CareCloud shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 7.5% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CareCloud has a net margin of 6.21% compared to OptimizeRx's net margin of 4.66%. CareCloud's return on equity of 27.07% beat OptimizeRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
OptimizeRx 4.66%9.44%7.11%

OptimizeRx has a consensus target price of $11.57, suggesting a potential upside of 37.92%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OptimizeRx
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

CareCloud has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Summary

OptimizeRx beats CareCloud on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Health Catalyst currently has a consensus price target of $2.45, suggesting a potential upside of 44.12%. Given Health Catalyst's higher possible upside, equities research analysts clearly believe Health Catalyst is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Health Catalyst and Health Catalyst both had 3 articles in the media. Health Catalyst's average media sentiment score of 0.79 beat CareCloud's score of 0.63 indicating that Health Catalyst is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Catalyst
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CareCloud has a net margin of 6.21% compared to Health Catalyst's net margin of -90.61%. CareCloud's return on equity of 27.07% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-90.61% -1.83% -0.80%
CareCloud 6.21%27.07%14.56%

CareCloud has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.41-$177.97M-$3.68N/A
CareCloud$120.50M0.72$10.80M$0.0729.14

Health Catalyst has a beta of 1.53, meaning that its share price is 53% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

Summary

CareCloud beats Health Catalyst on 8 of the 15 factors compared between the two stocks.

How does CareCloud compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

CareCloud has a net margin of 6.21% compared to Definitive Healthcare's net margin of -72.28%. CareCloud's return on equity of 27.07% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-72.28% 3.55% 1.63%
CareCloud 6.21%27.07%14.56%

Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

Definitive Healthcare presently has a consensus target price of $1.47, suggesting a potential upside of 57.19%. Given Definitive Healthcare's higher possible upside, equities research analysts clearly believe Definitive Healthcare is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
1.90
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CareCloud has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.41-$138.93M-$1.60N/A
CareCloud$120.50M0.72$10.80M$0.0729.14

In the previous week, Definitive Healthcare and Definitive Healthcare both had 3 articles in the media. CareCloud's average media sentiment score of 0.63 beat Definitive Healthcare's score of 0.60 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CareCloud beats Definitive Healthcare on 11 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCLD vs. The Competition

MetricCareCloudHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$86.69M$1.76B$7.22B$13.08B
Dividend YieldN/A3.95%2.53%15.88%
P/E Ratio29.1420.89272.6425.80
Price / Sales0.7286.21607.7390.99
Price / Cash2.9631.9177.3851.29
Price / Book1.466.1910.516.26
Net Income$10.80M-$26.60M$3.50B$360.95M
7 Day Performance-0.97%-0.57%-2.48%-1.89%
1 Month Performance-9.73%0.10%-5.65%-3.43%
1 Year Performance-39.10%-20.50%9.54%2.60%

CareCloud Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCLD
CareCloud
2.282 of 5 stars
$2.04
flat
N/A-36.4%$86.69M$120.50M29.143,650
ONMD
OneMedNet
0.9399 of 5 stars
$5.83
-8.0%
N/A-47.0%$345.36M$1.36MN/A2
AMWL
American Well
1.4266 of 5 stars
$13.51
+0.5%
$9.50
-29.7%
+121.0%$223.51M$249.32MN/A562
OPRX
OptimizeRx
4.3591 of 5 stars
$8.10
+3.6%
$11.57
+42.9%
-59.3%$152.70M$109.43M35.24105
HCAT
Health Catalyst
3.8806 of 5 stars
$1.72
-3.1%
$2.45
+42.9%
-39.3%$129.07M$311.14MN/A1,200

Related Companies and Tools


This page (NASDAQ:CCLD) was last updated on 10/1/2026 by MarketBeat.com Staff.
From Our Partners